Drugs Controller General of India (DCGI) Dr V G Somani has given permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The DCGI, however, put certain conditions like taking … Continue reading Serum institute gets nod to resume clinical trial of Oxford Covid vaccine